• Frontline
  • Warren Buffett
  • Volvo
  • NASDAQ Composite Index
  • 10 Year Treasury
  • Commercial Banks
  • JPMorgan Chase
  • Emerging Markets
  • Commerce Department
  • Home
  • Practice Management
  • Research & Insights
  • Alternatives
  • ETF Managed Portfolios
  • Home>Takeda Supports Launch of Five-Year, $1M Initiative Spearheaded by the Massachusetts Life Sciences Center to Back Women-Driven Early Stage Companies

    Takeda Supports Launch of Five-Year, $1M Initiative Spearheaded by the Massachusetts Life Sciences Center to Back Women-Driven Early Stage Companies

    Takeda Supports Launch of Five-Year, $1M Initiative Spearheaded by the Massachusetts Life Sciences Center to Back Women-Driven Early Stage Companies

    11/11/2017

    Takeda Supports Launch of Five-Year, $1M Initiative Spearheaded by the Massachusetts Life Sciences Center to Back Women-Driven Early Stage Companies

    Competitive Program to Award Two Recipients Annually with Funding and Mentorship –

    Takeda Pharmaceutical Company Limited (TSE:4502) today announced its support of the launch of the MassNextGen initiative, a five-year, $1M program anchored by Takeda and matched by the Massachusetts Life Sciences Center (MLSC), to support women-led or controlled early-stage biotech companies. This highly competitive program aims to provide a year-long customized package of support that includes funding and executive coaching. The announcement was made today at Takeda Boston, which included Massachusetts Governor Charles Baker.

    “Despite being essential members of the life sciences industry, women continue to be underrepresented, including at the executive level in which there remains a large gender gap,” said Christophe Bianchi M.D., President, Takeda Global Oncology Business Unit, Takeda Boston Site Head. “As an organization committed to diversity and inclusion, our contributions to the MassNextGen program and collaboration with the Massachusetts Life Sciences Center will further elevate the innovations that are being created by women-led companies, which have strong potential to make a difference in the future of our industry and the lives of patients.”

    “The strength of startup life sciences companies is critical to Massachusetts innovation economy and we are committed to building diversity and empowering more women entrepreneurs in this growing field,” said Governor Charlie Baker. “This initiative will help more women-led companies to thrive, leveraging additional sources of capital and support to create new jobs and bring cutting edge innovation to the marketplace.”

    “We are thrilled to begin this initiative with a strong partner in Takeda, and we look forward to collaborating with more companies, organizations and leaders to tackle this important issue,” said Lt. Governor Karyn Polito. “Through STEM-training initiatives and private sector partnerships like these, our administration is committed to increasing the representation of women in the life sciences.”